Research map: Phase 3 Randomized Study Investigating the Safety, Tolerability, and Immunogenicity of a Combination Modified Messenger RNA Vaccine Against Influenza and COVID-19 in Healthy Adults

Back to the article

Papers in this map

  1. mRNA vaccines — a new era in vaccinology · Norbert Pardi · 2018 · 4712 citations · Cited by this paper
  2. Site-Specific Glycosylation Profiling of Protein Subunit and Inactivated Virus Vaccines · 2026 · Related
  3. The value of childhood combination vaccines: From beliefs to evidence · Khaled Maman · 2015 · 161 citations · Cited by this paper
  4. Protection and Duration of 23-Valent Pneumococcal Polysaccharide Vaccine Against Hospitalization for Community-Acquired Pneumonia in Older Adults with Low Vaccination Coverage: A Multicenter Matched Case–Control Study in China · 2026 · Related
  5. Vaccine co-administration in adults: An effective way to improve vaccination coverage · Paolo Bonanni · 2023 · 120 citations · Cited by this paper
  6. A GM-CSF-Flt3L Fused Adjuvant Enhances Immune Responses and Protective Efficacy of Influenza DNA Vaccine in Mice · 2026 · Related
  7. Facilitating the development of urgently required combination vaccines · William P. Hausdorff · 2024 · 56 citations · Cited by this paper
  8. Association Between Varicella Vaccination Status and Self-Reported Contact History Among Confirmed Varicella Cases in Chaoyang District, Beijing, 2017–2025 · 2026 · Related
  9. Understanding the Global Burden of Influenza in Adults Aged 18–64 years: A Systematic Literature Review from 2012 to 2022 · Farzaneh Maleki · 2023 · 41 citations · Cited by this paper
  10. Awareness and Knowledge Levels of Cervical Cancer and HPV and Attitudes Toward HPV Vaccination in Algeria · 2026 · Related
  11. Efficacy, Immunogenicity, and Safety of Modified mRNA Influenza Vaccine · David Fitzpatrick · 2025 · 33 citations · Cited by this paper
  12. Bidirectional Interplay Between Tumor Vaccines and the Tumor Microenvironment: Mechanisms, Cold-to-Hot Conversion, and Combination Strategies · 2026 · Related
  13. Innovations, Challenges, and Future Prospects for Combination Vaccines Against Human Infections · Munazza Fatima · 2025 · 18 citations · Cited by this paper
  14. Advancing Influenza Prevention: The Case for Pre-Exposure Prophylaxis (PrEP) · 2026 · Related
  15. Post-viral sequelae of COVID-19 and influenza · Monica Gandhi · 2023 · 13 citations · Cited by this paper
  16. Yellow Fever Vaccination in an Individual with Confirmed Egg Protein Allergy: A Case Report · 2026 · Related
  17. Seasonal influenza vaccines: Variability of immune responses to B lineage viruses · Matthew S. Miller · 2024 · 11 citations · Cited by this paper
  18. Untangling the Roots of HPV Vaccine Acceptance in West Virginia: How Hesitancy and Misinformation Shape Parental Decisions · 2026 · Related
  19. A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of Nucleoside-Modified Messenger RNA Influenza Vaccines in Healthy Adults · Angela R Branche · 2025 · 11 citations · Cited by this paper
  20. A Multi-State, Cross-Sectional Retrospective Study on Knowledge, Attitude and Practice of Rabies Post-Exposure Prophylaxis Including Rabies Monoclonal Antibody Among Physicians Across India · 2026 · Related
  21. Scenario Projections of COVID-19 Burden in the US, 2024-2025 · Sara L. Loo · 2025 · 8 citations · Cited by this paper
  22. Comparison of the Hemagglutination Inhibition Titers against Influenza Vaccine Strains in Japan from the 2017/2018 to 2021/2022 Seasons Using a Single Set of Serum Samples · Naruhito Otani · 2022 · 2 citations · Cited by this paper
  23. Estimating the value of combination vaccines: a methodological framework · Mark Jit · 2025 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)